The protein encoded by this gene is an ATP-dependent DNA ligase that joins double-strand breaks during the non-homologous end joining pathway of double-strand break repair. It is also essential for V(D)J recombination. Lig4 forms a complex with XRCC4, and further interacts with the DNA-dependent protein kinase (DNA-PK) and XLF/Cernunnos, which are also required for NHEJ. The crystal structure of the Lig4/XRCC4 complex has been resolved. Defects in this gene are the cause of LIG4 syndrome. The yeast homolog of Lig4 is Dnl4.
LIG4 has been shown to interact with XRCC4 via its BRCT domain. This interaction stabilizes LIG4 protein in cells; cells that are deficient for XRCC4, such as XR-1 cells, have reduced levels of LIG4.
LIG4 is an ATP-dependent DNA ligase. LIG4 uses ATP to adenylate itself and then transfers the AMP group to the 5' phosphate of one DNA end. Nucleophilic attack by the 3' hydroxyl group of a second DNA end and release of AMP yield the ligation product. Adenylation of LIG4 is stimulated by XRCC4 and XLF.
^Mahaney BL, Hammel M, Meek K, Tainer JA, Lees-Miller SP (February 2013). "XRCC4 and XLF form long helical protein filaments suitable for DNA end protection and alignment to facilitate DNA double strand break repair". Biochem. Cell Biol.91 (1): 31–41. doi:10.1139/bcb-2012-0058. PMID23442139.
Grawunder U, Zimmer D, Fugmann S, et al. (1998). "DNA ligase IV is essential for V(D)J recombination and DNA double-strand break repair in human precursor lymphocytes". Mol. Cell2 (4): 477–84. doi:10.1016/S1097-2765(00)80147-1. PMID9809069.
Kim ST, Lim DS, Canman CE, Kastan MB (2000). "Substrate specificities and identification of putative substrates of ATM kinase family members". J. Biol. Chem.274 (53): 37538–43. doi:10.1074/jbc.274.53.37538. PMID10608806.
Chen L, Trujillo K, Sung P, Tomkinson AE (2000). "Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase". J. Biol. Chem.275 (34): 26196–205. doi:10.1074/jbc.M000491200. PMID10854421.
Lee KJ, Huang J, Takeda Y, Dynan WS (2000). "DNA ligase IV and XRCC4 form a stable mixed tetramer that functions synergistically with other repair factors in a cell-free end-joining system". J. Biol. Chem.275 (44): 34787–96. doi:10.1074/jbc.M004011200. PMID10945980.
Riballo E, Doherty AJ, Dai Y, et al. (2001). "Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity". J. Biol. Chem.276 (33): 31124–32. doi:10.1074/jbc.M103866200. PMID11349135.
Sibanda BL, Critchlow SE, Begun J, et al. (2002). "Crystal structure of an Xrcc4-DNA ligase IV complex". Nat. Struct. Biol.8 (12): 1015–9. doi:10.1038/nsb725. PMID11702069.
O'Driscoll M, Cerosaletti KM, Girard PM, et al. (2002). "DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency". Mol. Cell8 (6): 1175–85. doi:10.1016/S1097-2765(01)00408-7. PMID11779494.
Kuschel B, Auranen A, McBride S, et al. (2002). "Variants in DNA double-strand break repair genes and breast cancer susceptibility". Hum. Mol. Genet.11 (12): 1399–407. doi:10.1093/hmg/11.12.1399. PMID12023982.